Search research articles
Contact Us
Filters
Showing results (11-20 of 90) with videos related to
Page
of 9
Sort By:
In Vivo (Athens, Greece)
|
November 1, 1993
Serum marker combinations in human breast cancer (review)
R Lamerz, P Stieber, A Fateh-Moghadam
Anticancer Research
|
July 1, 1997
Value of HAMA--determination in clinical practice--an overview
U Hasholzner, P Stieber, W Meier, et al.
Anticancer Research
|
September 2, 1999
Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases
R Lamerz, M Runge, P Stieber, et al.
Anticancer Research
|
July 1, 1997
Significance of tumor marker determinations in the primary therapy of ovarian cancer
W Meier, L Baumgartner, P Stieber, et al.
Anticancer Research
|
July 1, 1997
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma
W Meier, P Stieber, U Hasholzner, et al.
Anticancer Research
|
July 1, 1997
Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma
S Poley, P Stieber, V Nüssler, et al.
Anticancer Research
|
July 1, 1997
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma
S Poley, P Stieber, V Nüssler, et al.
Anticancer Research
|
March 12, 1998
Alpha 1-antichymotrypsin-PSA (ACT-PSA): a useful marker in the differential diagnosis of benign hyperplasia and cancer of the prostate?
W Reiter, P Stieber, N Schmeller, et al.
Geburtshilfe Und Frauenheilkunde
|
September 1, 1992
[Prognostic significance of the CA 125 half-life for the further outcome of ovarian cancer]
W Meier, P Stieber, A Fateh-Moghadam, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 1989
[Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix]
W Meier, W Eiermann, P Stieber, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 90) with videos related to
Sort By:
Page
of 9
In Vivo (Athens, Greece)
|
November 1, 1993
Serum marker combinations in human breast cancer (review)
R Lamerz, P Stieber, A Fateh-Moghadam
Anticancer Research
|
July 1, 1997
Value of HAMA--determination in clinical practice--an overview
U Hasholzner, P Stieber, W Meier, et al.
Anticancer Research
|
September 2, 1999
Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases
R Lamerz, M Runge, P Stieber, et al.
Anticancer Research
|
July 1, 1997
Significance of tumor marker determinations in the primary therapy of ovarian cancer
W Meier, L Baumgartner, P Stieber, et al.
Anticancer Research
|
July 1, 1997
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma
W Meier, P Stieber, U Hasholzner, et al.
Anticancer Research
|
July 1, 1997
Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma
S Poley, P Stieber, V Nüssler, et al.
Anticancer Research
|
July 1, 1997
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma
S Poley, P Stieber, V Nüssler, et al.
Anticancer Research
|
March 12, 1998
Alpha 1-antichymotrypsin-PSA (ACT-PSA): a useful marker in the differential diagnosis of benign hyperplasia and cancer of the prostate?
W Reiter, P Stieber, N Schmeller, et al.
Geburtshilfe Und Frauenheilkunde
|
September 1, 1992
[Prognostic significance of the CA 125 half-life for the further outcome of ovarian cancer]
W Meier, P Stieber, A Fateh-Moghadam, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 1989
[Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix]
W Meier, W Eiermann, P Stieber, et al.
Page
of 9